Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced participation in a panel discussion at the B. Riley Securities Precision Oncology & Radiopharma Investor Conference that will ...

Dr. Marc Siegel from NYU Langone Health confirmed that a small percentage of vaccinated people suffering from prolonged side ...

Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its fourth quarter and year end 2024 ...

Your immune system harbors a lifetime's worth of information about threats it's encountered - a biological Rolodex of baddies ...

Receptors on B and T cells hint at what the immune system is targeting. An AI approach called Mal-ID developed increases diagnostic accuracy, particularly for autoimmune diseases.

A machine learning algorithm that analyzes immune "fingerprints" could be used to detect complex, hard-to-diagnose diseases.